Vaccines have eradicated some of the deadliest infectious diseases known to man, yet scientists have been challenged by the inability to create vaccines for all pathogens in the past. Recently, scientists have focused on the DNA of microbes to help develop vaccines by using a technique called “Reverse Vaccinology”. This efficient and cost-effective approach is expected to revolutionize vaccine development in the 21st century and is also being used as a promising approach for the treatment of cancer and antibiotic resistance.
Bhavna is a young researcher at the National Institute of Molecular Genetics (INGM) in Milan, Italy. Her Alma Mater is the Florida Institute of Technology from which she graduated with honors in Biochemistry. She continued her education at ETH Zurich where she gained a Microbiology and Immunology master degree with research experience centered on human nutrition, food microbiology and biochemistry. She is now actively involved in the research of human regulatory T-cells in cancer.